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Background: Vaginal metastases originating from colorectal carcinoma are very rare. Due to the limited
number of reported cases, there is no proposed standard treatment and little is known about its man-
agement outcome.
Aim: The aim of this article is to review the available literature to establish the clinical presentation,
trends in treatment and prognosis of vaginal metastases from colorectal malignancy.
Methods: A literature search using keywords used for database search were ‘colorectal carcinoma’,
‘colorectal cancer’, ‘colon cancer’ and ‘vaginal metastasis’.
Results: Of the 30 articles identiﬁed, 37 reported cases, were accessible for full evaluation. Cases reported
originates from various countries and majority presented with vaginal bleeding. Diagnosis was estab-
lished after histological examination and treatment options consist of surgical resection, radiotherapy or
chemotherapy that have been used individually or in combination. Association with disseminated
metastatic disease indicates ominous prognosis as seen in 32.4% (n ¼ 12) cases.
Conclusion: Vaginal metastasis of colorectal cancer should be included in the differential diagnosis of a
vaginal swelling. There is no proposed standard treatment for vaginal metastases but surgical resection is
an appropriate approach for local control when no disseminated metastatic disease is documented.
 2013 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Colorectal cancer is one the most common types of cancer in
Western countries. In the United States of America, it ranks fourth
as cause of cancer. The most frequent sites for systemic spread are
the liver and lungs. More rarely, the disease spreads to the brain or
bones. However, metastases from colorectal cancer to the vagina
are extremely rarely reported. More frequently, vaginal involve-
ment in colorectal cancer occurs by direct contiguous spread from
the primary tumour. To date, only 49 cases of vaginal metastasis
from colorectal cancer have been reported in 30 articles.1e30
Whitelaw et al.1 published the ﬁrst report of vaginal metastasis
from colorectal cancer in 1956, which was a case of vaginal lesion
from sigmoid adenocarcinoma. The second report was in 1966 by
Raider, which included a series of four cases of vaginal adenocar-
cinoma from colon cancer were presented. The vaginal lesions were
diagnosed between 4 and 41 months after colonic resection and inurgery & Training Unit, Uni-
sterhill, Aberdeen AB25 2ZN,
ciates Ltd. Published by Elsevier Ltthree of the four cases, the overall survival was less than 40 months
due to metastasis to other organs.2
Cases of vaginal metastases from colorectal cancer continue to
be rare or possibly under-reported. These lesions often present a
diagnostic & therapeutic challenge and due to the limited number
of reported cases, there is no proposed standard treatment and
little is known about its management outcome.
To date, all the published literature on vaginal metastases from
colorectal cancer consist of case reports only with limited guidance
to assist clinicians faced with patients with such rare, but clinically
important, condition. The aim of this article is to review the avail-
able literature to establish the clinical presentation, trends in
treatment and prognosis of vaginal metastases from colorectal
malignancy.2. Methods
A literature search using PubMed and Ovidsp, which includes database of
Embase, EBM reviews, Medline, CAB Abstracts and AMED was performed. Keywords
used for database search were ‘colorectal carcinoma’, ‘colorectal cancer’, ‘colon
cancer’ and ‘vaginal metastasis’.
The search had no limitation on study type, period of publication or language. A
further search for additional case reports from the reference lists provided by the
identiﬁed articles was done. Duplicates were removed and the abstracts of the
selected titles were screened for eligibility. Inclusion criteria were all articlesd. All rights reserved.
Table 1
Review of vaginal metastasis from colorectal carcinoma.
Author; year Country Age (year) Primary colorectal
carcinoma location
Classiﬁcation of
primary colorectal
carcinoma
Type of
surgery þ other
treatments for
primary lesion
Metastatic vaginal
location
Other metastases Treatment for vaginal
(V) and other
metastases (M)
Survival
following
vaginal lesion
(mo)
Whitelaw et al.; 19561
Case 2
US 52 Mid-sigmoid Adenocarcinoma Resection Lateral wall Urethra V- resection, radium
therapy
M-radium therapy
39
Raider; 19662
Case 1
US 47 Mid- descending Grade III
Dukes B
Left colectomy Posterior fornix left Brain, omentum,
peritoneum
V þ M-radium therapy 39
Raider; 19662
Case 2
US 48 Mid-sigmoid Grade II
Dukes C
Left colectomy,
total hysterectomy,
radiation therapy
Vaginal vault Ovaries, uterus,
pleura, liver
V- radium therapy 21
Raider; 19662
Case 3
US 63 Distal descending
junction with sigmoid
Grade II
Dukes C
Left colectomy Introitus left None V- resection, nitrogen
mustard, radiation
therapy
Alive at the
time of report
Raider; 19662
Case 4
US 46 Proximal sigmoid
junction with
descending
Grade II
Dukes C
Resection Vaginal vault left Ovary, ileum,
peritoneum, liver,
mediastinum
V- radium therapy 10
Lee SM et al.; 19743 Case 3 US 81 Recto-sigmoid Dukes C Anterior resection,
transverse
colostomy
Anterior wall None V- excision Alive at the
time of report
Lee SM; 19743 Case 4 US 57 Sigmoid Dukes C Segmental sigmoid
resection
Introitus None V- radiation Alive at the
time of report
Singh P et al.; 19875 SG 56 Descending colon Dukes D
Moderately
differentiated
adenocarcinoma
Segmental
resection
Apex Peritoneal cul-de-
sac, para-aortic
lymph node
V þ M- resection Alive at the
time of report
Jotkowitz; 19886 Australia 43 Recto- sigmoid Well differentiated
adenocarcinoma
Resection,
colostomy
Vaginal vault Anterior abdominal
wall
V- partial colectomy,
chemotherapy,
radiotherapy
24
Kudo et al.; 19888 Japan 66 Sigmoid Dukes B
Moderately
differentiated
adenocarcinoma
Sigmoidectomy Anterior wall right Liver V- resection
M-tumorectomy
Alive at the
time of report
Yokoyama et al.; 19899 Japan 48 Descending colon Dukes B
Well differentiated
adenocarcinoma
Surgery Posterior fornix left Peritoneum V þ M- chemotherapy 41
Hiroyuki et al.; 199610 Japan 60 Rectum Dukes C
Moderately
differentiated
adenocarcinoma
Anterior resection Introitus Para-aortic lymph
node
V- resection
M- chemotherapy
Alive at the
time of report
Perrotin F et al.; 199711 France 61 Rectum Moderately
differentiated
adenocarcinoma
Abdominal
colorectal resection
with colorectal
anastomosis
Anterior wall None V-colpectomy, external
beam to pelvic and
inguinal, interstitial
brachytherapy
Alive at the
time of report
Nakamura et al.; 199912 Japan 74 Rectum Moderately
differentiated
adenocarcinoma
Low anterior
resection
Left wall Liver V- resection
M-tumorectomy
Alive at the
time of report
Yamamoto et al.; 199913
Case 1
Japan 47 Rectal Dukes D
Moderately
differentiated
adenocarcinoma
Hartmann’s
procedure
Vaginal vault Liver, bone, bladder V- resection,
radiotherapy
M- hepatectomy,
chemotherapy
29
Yamamoto et al.; 199913
Case 2
Japan 46 Rectal Dukes C
Well to moderately
differentiated
adenocarcinoma
Abdomino-perineal
resection
Vaginal oriﬁce Uterus V- resection
M- radiotherapy
Alive at the
time of report
Yamamoto et al.; 199913
Case 3
Japan 59 Cecal Ileocecal resection Anterior wall right Liver, lung,
peritoneum, ovary
7
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Table 1 (continued )
Author; year Country Age (year) Primary colorectal
carcinoma location
Classiﬁcation of
primary colorectal
carcinoma
Type of
surgery þ other
treatments for
primary lesion
Metastatic vaginal
location
Other metastases Treatment for vaginal
(V) and other
metastases (M)
Survival
following
vaginal lesion
(mo)
Dukes C
Poorly differentiated
adenocarcinoma
V- resection
M- chemotherapy,
radiotherapy
Ramia et al.; 200014 Spain 46 Rectum Well differentiated
adenocarcinoma
Low anterior
resection
Left lateral wall near
introitus
Ovary V- resection
M- salpingo-
oophorectomy
Alive at the
time of report
Chagpar A et al.; 200115 Canada 83 Mid-sigmoid Moderately to poorly
differentiated
adenocarcinoma
Sigmoid colectomy,
Hartmann’s
procedure
Anterior wall right Liver, skin Not mentioned Not mentioned
Katsumoto Y et al.; 200216 Japan 55 Rectum Moderately
differentiated
adenocarcinoma
Hartmann’s
procedure,
resection of right
ureter, uterus and
left ovary,
chemoradiotherapy
Not mentioned Ureter, uterus,
ovary
V- resection
M- abdomino-perineal
resection, simple total
hysterectomy, bilateral
salpingo-
oophorectomy
Alive at the
time of report
Komori et al.; 200317 Japan 74 Sigmoid Moderately
differentiated
adenocarcinoma
Sigmoidectomy Vaginal vault right Liver V- resection Not mentioned
Yagci G et al.; 200518 Turkey 44 Rectum Poorly differentiated
adenocarcinoma
Low anterior
resection,
tumorectomy of
liver nodule,
chemotherapy
Anterior wall Liver V- intracavitary
radiation and
chemotherapy
M- tumorectomy
Not mentioned
Marchal F et al.; 200619 France 81 Sigmoid Tubulovillous
adenocarcinoma
Sigmoidectomy
with total
hysterectomy,
bilateral salpingo-
oophorectomy
Lower third of vaginal
wall
None V- external beam
therapy of perineal
area, brachytherapy,
local excision
Alive at the
time of report
Aella S et al.; 200720 UK 60 Recto-sigmoid Not mentioned Sigmoid loop
colostomy
Vaginal vault right Ovary, ureter,
bladder base
V- chemotherapy,
radiotherapy
Not mentioned
Costa SRP et al.; 200921 Brazil 67 Right colon Moderately
differentiated
adenocarcinoma
Right
hemicolectomy
Anterolateral face left None V- local resection with
wide margins with
primary closure,
adjuvant radiotherapy
Alive at the
time of report
Funada T et al.; 201022 Japan 63 Rectum Well to moderately
differentiated
adenocarcinoma
Abdominoperineal
resection
Vaginal oriﬁce None V- partial colpectomy,
post operative
radiotherapy
Alive at the
time of report
Ceccaroni M et al.; 201023 Italy 72 Rectum Grade II
Dukes D
Rectosigmoid
resection with
mechanical
terminaleterminal
colorectal
anastomosis
Posterior wall of
vaginal
Ovary V- resection
M- bilateral
oophorectomy,
adjuvant
chemotherapy
Alive at the
time of report
Ferreiro GE et al.; 201024 Spain 74 Caecum Moderately
differentiated
adenocarcinoma
Right
hemicolectomy,
chemotherapy
Introitus and anterior
wall of vagina
Retroperitoneal,
para-aortic and
peribronchial
lymph node uterus,
liver, peritoneum,
lungs, mediastinal
lymph node,
Not mentioned 34
Elvira UA et al.; 201025
Case 1
Spain 67 Right colon Moderately
differentiated
adenocarcinoma
Right
hemicolectomy,
chemotherapy
Left wall Lung, liver Not mentioned 9
Elvira UA et al.; 201025
Case 2
Spain 60 Rectum Not mentioned Posterior fornix Liver, lung, adrenal,
bone
V- not mentioned
M- chemotherapy
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REVIEWreporting vaginal metastasis from colorectal cancer. Only duplicate case reports
were excluded. Non-English articles & abstracts were translated to English.
A full text review was performed on the eligible articles and the signiﬁcant
features pertaining to patients with vaginal metastasis from colorectal cancer un-
derwent data extraction. Data extracted (Table 1) included ﬁrst author, publication
year, country and age of patient, location and classiﬁcation of the primary tumour,
treatment of primary lesion, location and treatment of vaginal metastasis and other
metastases and period of mortality after vaginal metastasis.3. Results
Twenty-seven articles had accessible full-text1e8,11e15,17e30 and
three articles9,10,16 had accessible abstract generating 49 case re-
ports. Two articles, one4 reported 11 cases of vaginal metastasis
from colorectal cancer and one7 reported one case of vaginal
metastasis from sigmoid cancer of did not have full descriptions of
the lesion hence only 37 case reports were evaluated for data
extraction (Fig. 1).
The 49 case reports have been reported from various
countries with 18 (36.7%) reported cases originated from US in 4
articles,1e4 12 (24.5%) cases in 10 articles reported from Japan,8e
10,12,13,16,17,22,29,30 6 (12.2%) cases in 4 articles from Spain,14,24,25,28
4 (8.2%) cases in 3 articles reported from France11,19,27 and Brazil
reported 2 (4.1%) cases.21,26 Other reported cases include countries
of South Africa, Canada, Turkey, Italy, UK, Australia and Singapore
where each reported one case (2%).3.1. Clinical presentation
Case reports of 37 cases were analysed in this review (Table 2).
The average age at the time of presentation was 60.6 years, with a
range of 43 yearse83 years. The majority of patients (51.4%, n ¼ 19)
presented with vaginal bleeding. However, 5.4% (n ¼ 2) presented
with vaginal discharge, 2.7% (n ¼ 1) presented with vaginal stain-
ing, 10.8% (n ¼ 4) presented with vaginal mass and 2.7% (n ¼ 1)
presented with perineal discomfort. A total of 10.8% (n ¼ 4) did not
have gynaecological or colorectal symptoms, but were found to
have vaginal mass during routine gynaecological examination in
5.4% (n ¼ 2) and after a follow-up CT scan for ovarian cancer in
another 5.4% (n ¼ 2). Interestingly, 27% (n ¼ 10) of the reported
cases in the literature were without known previous history of
colorectal carcinoma. These patients presented with vaginal
symptoms and metastatic colorectal cancer was diagnosed after
biopsy of the vaginal lesion. In 16.2% (n ¼ 6) of cases, there was no
mention of the presenting complaint (Fig. 2).3.2. Diagnosis
Of the 37 accessible reported cases, 97.3% (n ¼ 36) were diag-
nosed as vaginal metastasis of colorectal carcinoma after biopsy &
histological examination and 2.7% (n ¼ 1) was diagnosed by liquid
based cytology and immunochemistry study.3.3. Treatment
Therapeutic options for the vaginal lesion were surgical resec-
tion, radiotherapy and chemotherapy used individually or in
combination. Surgical resection as the only treatment were re-
ported in 21.6% (n ¼ 8) of the cases, 18.9% (n ¼ 7) were treated with
surgical resection and radiotherapy and 13.5% (n ¼ 5) were treated
with surgical resection and chemotherapy. Radiotherapy was used
as the only treatment for 13.5% (n ¼ 5) while 2.7% (n ¼ 1) had
chemotherapy as the only treatment. Combination of radiotherapy
and chemotherapy were used in 8.1% (n ¼ 3) and 10.8% (n ¼ 4) had
surgical resection, chemotherapy as well as radiotherapy as
Embase, EBM reviews, Medline, 
CAB Abstracts, AMED and article’s 
Fig. 1. PRISMA diagram.
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REVIEWtreatment. There were 10.8% (n ¼ 4) of case reports where the
treatment for the vaginal mass was not mentioned (Fig. 3).
Overall, the use of chemotherapy was reported in 11 arti-
cles6,9,10,13,18,20,23,25e27,29, however most of the articles did not
specify the exact nature of the chemotherapeutic agent used or the
duration of the treatment. Chemotherapeutic agents used were 5-
ﬂuorouracil13 as well as ﬂuoropyridine and MFOLFOX6.29
There were three case reports13,27,29 that involved single agent
chemotherapy while another two case reports18,23 involved com-
bination of chemotherapy agents as treatment. The single chemo-
therapy agent that were used included ﬂuorouracil (5FU),13
irinotecan,27 ﬂuoropyridine and NFOLFOX29 while combination
chemotherapy agents included oxaliplatin with capecitabine23 and
ﬂuorouracil (5FU) with calcium leucovorin.18 There were six case
reports6,9,10,20,25,26 that did not mention the chemotherapy agent.
3.4. Prognosis
It was difﬁcult to ascertain the overall prognosis or survival as
such data were not universally available so we had to rely on sur-
vival at the time of writing the case report, which gives relatively
limited insight on the true prognosis in these patients. Taking this
into account, 21.6% (n¼ 8) of patients who presented with no other
metastases, apart from the vaginal metastases, and had resection ofthe primary carcinoma where all were free of disease and had no
recurrence reported after treatment for the vaginal metastasis at
the time of case report. On the other hand, 2.7% (n ¼ 1) of cases
reported with no other metastases besides to the vagina had
recurrence after having radiotherapy as the only treatment but was
still alive at the time of report. Also, there were 29.7% (n ¼ 11) of
reported cases were alive at the time of case report even with
presence of metastases to other organs.
Control of the metastases was achieved by tumorectomy and
administration of adjuvant therapy such as chemotherapy and
radiotherapy. As seen in most of the reported cases, association
with disseminated metastatic disease indicates ominous prognosis.
There were 32.4% (n ¼ 12) who had limited survival due to the
metastases to other organs with two died of brainmetastasis. There
were no mention about survival after vaginal lesion was diagnosed
in 13.5% (n ¼ 5).
4. Discussion
Primary vaginal carcinomas are very uncommon and it accounts
for only 2% of all malignant lesions of female genital system.31 They
are most commonly squamous cell carcinomas (86%), very rarely
adenocarcinoma (8%) or other histological types (7%). The majority
of vaginal adenocarcinomas are often secondary to uterine
Fig. 3. Treatment modalities used for vaginal metastasis from colorectal cancer.
Table 2
Summary of the review on vaginal metastasis.
Previous diagnosis of colorectal malignancy
Yes 26 70.3
No 11 29.7
Clinical presentation
Vaginal bleeding 19 51.4
Vaginal discharge 215,21 5.4
Vaginal staining 11 2.7
Vaginal mass 42,3,12,13 10.8
Perineal discomfort 123 2.7
Asymptomatic 47,13,25,27 10.8
Not stated 62,2,3,25,25,26 16.2
Conﬁrmation of diagnosis
Histology 36 97.3
Fine needle aspiration cytology 128 2.7
Treatment
Surgical resection only 83,5,8,12,14,16,17,28 21.6
Surgical resection & radiotherapy 71,2,11,13,19,21,22 18.9
Surgical resection & Chemotherapy 510,23,25,27,29 13.5
Radiotherapy only 52,2,2,3,30 13.5
Chemotherapy only 19 2.7
Radiotherapy & chemotherapy 318,20,26 8.1
Surgical resection & radiochemotherapy 46,13,13,27 10.8
Not stated 415,24,25,25 10.8
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REVIEWadenocarcinoma, rarely to other tumours such as kidney, breast or
pancreas.19 When colorectal cancer metastasizes to the female
genital tract, ovaries are the most frequent site followed by vagina
and endometrium.4 Therefore, vaginal metastases from colorectal
cancer are relatively rare with limited number of cases reported in
the literature. Consequently, there is neither consensus on the
surgical treatment nor a clear policy on the use of chemotherapy
and/or radiotherapy.
The majority of the reported cases of vaginal metastasis from
colorectal cancer originate from primary tumours located in the
rectum or sigmoid colon. It is well known that there are subtle
variations in the technique of rectal cancer surgery resection
across the world, in particular regarding the routine use of rectal
washout which is thought to reduce viable tumour cells in the
rectal stump that might, theoretically, result in local tumour im-
plantation. It was not possible from the reported literature to
determine if these patients had rectal washout at the time of
surgical resection of their primary. The fact that there are reports
from various countries across the world make it less convincing
that variations in surgical technique would account for developing
vaginal metastases by tumour implantation at the time of surgery.Fig. 2. Clinical presentation of vaginal metastasis from colorectal cancer.However, the limited number of cases makes it difﬁcult to reach
deﬁnite conclusions.
Four mechanisms of spread of colorectal cancer to the vagina
have been proposed. The ﬁrst suggested route of spread is by local
invasion where direct extension of the primary tumour occurs
through the ischiorectal fossa and junction of the deep and su-
perﬁcial perineal membranes.19 However, this route is not possible
for vaginal metastasis from other primaries at distant sites such as
breast carcinomas. The second proposed course of spread is via
transcoelomic route where tumour cells could be implanted in the
Fallopian tube or uterus and subsequently to the vagina.19 Given
that some of the patients in the reported cases had hysterectomy
before the metastasis, this theory is not strongly agreed upon.
The other two suggested metastatic routes are lymphatic and
haematogenous spread.2 For lymphatic spread, there is a possibility
of metastasis from the sigmoid colon lymphatics to the iliac and
hypogastric lymph nodes where retrograde spread to the periure-
thral area and anterior vaginal wall occur.21 Also, it is recognized
that there is communication between posterior vaginal wall and
rectal lymphatics. Therefore, it has been suggested that retrograde
spreadmay also occur from the rectal lymph nodes. This view is not
universally accepted, as there are few reported cases of vaginal
metastases from lymph node negative colorectal tumours. As for
haematogenous route, venous channels may allow metastatic cells
to travel from the primary site in the colon to the ovarian plexus or
parametrial veins and then to the vaginal veins.2 This last hypoth-
esis seems the most appropriate route to explain vaginal metasta-
ses from colorectal cancer. However, it should be acknowledged
that there are many uncertainties regarding the available case re-
ports on vaginal metastases as most of the available articles did not
explicitly state if the lesions were thought to be related to hae-
matogenous or lymphatic metastases rather than “drop metasta-
ses” or direct extension.
Presentation of colorectal cancer with vaginal bleeding is
atypical and very rare. Some of the reported cases1,5,6,10,11,13,17,19,20,23
presented with vaginal bleeding and were diagnosed with the
vaginal metastases before the colorectal primary lesion was diag-
nosed. Therefore, biopsy and thorough histopathological evaluation
is vital to determine the site of origin of the lesion. Besides that,
female patients with history of rectal or sigmoid carcinoma that
present with vaginal bleeding or sensation of a lump in the vagina
should have an urgent gynaecological examination to exclude local
metastasis.
There is no agreement on the management of vaginal metas-
tases from colorectal cancer. Management options that were
documented in these reported cases comprised of local excision of
H.J. Ng, E.H. Aly / International Journal of Surgery 11 (2013) 1048e10551054
REVIEWthe vaginal mass or colpectomy, radiotherapy that included
external beam therapy or interstitial brachytherapy, chemotherapy
when multiple metastatic sites were involved and tumorectomy
with hysterectomy and bilateral salpingo-oophorectomy when
ovaries and uterus were involved. Therefore, there is no proposed
standard treatment for vaginal metastases. Nevertheless, surgical
excision of remote vaginal metastasis from colorectal carcinoma
would be an appropriate approach for local control.
Earlier reports suggested that vaginal metastases of colorectal
cancer are associated with poor prognosis especially when there
are multiple sites of metastatic disease. However, we noted a
change over time in the management of vaginal metastases from
colorectal cancer with shift towards a more aggressive approach in
the diagnosis and treatment in more recent reports. Clearly, there
were relatively long-term survivors when no metastases besides
the vagina2,3,11,19,21,22,27 were diagnosed.
Interestingly, four patients11,19,27 reported from France had the
best overall survival because all four (10.8%) patients in the three
articles had no metastases and survived even though two of the
patients presented without symptoms of colorectal carcinoma.
Three11,27 (8.1%) of the cases had primary lesion at the rectum and
had rectal resection followed by resection of the vaginal metastasis
and radiotherapy and or chemotherapy. Other cases2,10,11,13,19,21e
23,27,29 also had adjuvant therapy by means of chemotherapy or
radiotherapy with good overall survival. Hence, it seems that
adjuvant therapy following resection of vaginal metastases could
potentially offer some survival beneﬁt as shown by the 27% (n¼ 10)
of cases that received adjuvant therapy. However, due to the limited
number of reported cases and variation as well as lack of details of
the adjuvant therapy regimens used it would be difﬁcult to be
certain of this recommendation.
It should be noted that this review has several limitations as it
mainly relies on case reports with variable quality as well as limited
number of cases. Also, there could be reporting bias of vaginal
metastases from colorectal cancer with cases under-reported,
misdiagnosed or tendency to report cases with more favourable
outcome. Consequently, the actual incidence, response to treat-
ment, survival as well as the outcomemight be different fromwhat
could be established from the available literature.
This review emphasizes the paucity of evidence in the current
literature that might increase the awareness with the condition and
encourage reporting similar cases in the future. Also, highlighting
the limitations in the currently available case reports might
improve the quality of data included in future publications.
Due to the limitations we have encountered in constructing
evidence from the available literature in this review, we recom-
mend that future case report should include data pertaining to site
of the colorectal primary, mode of presentation of the vaginal
metastasis from colorectal cancer, how was the diagnosis estab-
lished and details of any surgical treatment offered. It would also be
vital to include detailed information on radiotherapy or chemo-
therapy treatment with exact duration and dosage. Data related to
survival could be more difﬁcult to report accurately as most of the
case reports are made following the diagnosis rather than patient’s
death.
Nevertheless, this review would be a useful tool for clinicians
faced with this rare condition to be aware of the various treatment
modalities that have been used in the past, to guide them on the
various options in management and give some insight on the
prognosis.
5. Conclusion
Vaginal metastases from colorectal cancer should be included in
the differential diagnosis in patients presenting with vaginalbleeding or sensation of a vaginal swelling. When such presenta-
tion occurs in patients with history of colorectal carcinoma, a
thorough gynaecological assessment should be done. Even though
there is no consensus on treatment, this review highlights that the
available limited evidence suggests that isolated vaginal metastasis
from colorectal cancer that is amenable to local surgical resection
has reasonable outcome. Also, evidence suggests that adjuvant
therapy would be a rational adjunct. However, vaginal metastasis
from colorectal cancer in the context of diffuse metastatic disease
portends poor prognosis.
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